Buy Complete Report

Prix: €120 HT

Logo CreditCards Visa Logo CreditCards Mastercard

This report is accessible on EMAT, the reference database for private company acquisition multiples



► Subscribe to EMAT database


Sectors covered by our analysts


► Studies & indices published by Epsilon Research: Register to receive (free) publications updates


► Alert on reports published: Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.


Transaction Multiples for the Valuation of Private Companies

Boticinal / Ceido (Centre Européen d’Intérêt et de Développement de l’Officine)

No EMAT : 111449
Announced Date : 02/10/2022
Type : Acquisition of Majority Stake
Deal Value : Yes
Acquirer : Boticinal

Target : Ceido (Centre Européen d’Intérêt et de Développement de l’Officine)
Country : Paris
Sector of activity :
  • Pharmaceuticals & Cosmetics R&W > Retail and Wholesale ('R&W') > Drugs Retailers
Business Description :
Founded in 1988 by pharmacists, CEIDO is a pharmacy network. > Offers to its members the following services: referencing; central purchasing; data platform; brokerage. > Network of 131 pharmacies...

Transaction multiples available
Gross Profit
P/E Price
to Book
Rating : *
Multiple available
n.s.   Multiple calculated, but not significant

Source: Epsilon Research / EMAT

Comparable Transactions

  • Number of EMAT Reports / sub-sector « Drugs Retailers » = 47
Example of comparable transactions on EMAT (same sub-sector):
Date Acquirer Target Country Multiples See details
22/02/2022 Airbus, Safran and Tikehau ACE Capital AD Aubert & Duval France ** 111718
30/09/2004 NWD Group Plc Clinic Group Ltd United Kingdom ** 10235

Source: Epsilon Research / EMAT

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).


► Example of EMAT Report